Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine

Recruiting now · Phase 4

Conditions studied: Postoperative Pain Management

In brief

The investigators are evaluating postoperative outcomes in patients undergoing hip replacement surgery performed with either spinal or general anesthesia, who also receive a suprainguinal fascia iliaca block using either perineural ropivacaine alone or ropivacaine combined with dexmedetomidine.

Key facts

Study ID

NCT07316166

Run by

Rhode Island Hospital

People needed

120

Starts

2026-01-20

Expected to finish

2027-06-01

Last updated by the study team

2026-03-25

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing elective total hip arthroplasty
• 18-80 years old
• ASA 1-3 classifications

You may not qualify if…

• ASA classification of 4 or greater
• Infection at the site of nerve blockade
• Coagulopathy
• Known allergy to study medications
• Chronic opioid consumption (>3 months)
• Currently using lidocaine patches
• Pre-existing neuropathy
• A history of CVA
• High grade atrioventricular block (cardiac conduction system impairment)
• Organ dysfunction (cardiac failure, respiratory failure, end stage renal disease, hepatic dysfunction, hypoalbuminemia)
• Morbid obesity (≥40 kg/m2)
• Prior surgery in supra and/or infrainguinal region
• Non-English-speaking participants

Where it is running

• The Miriam Hospital — Providence, Rhode Island, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.